Skip to main content
. 2014 Apr 11;14(2):73–83. doi: 10.1007/s40268-014-0041-0

Fig. 4.

Fig. 4

Survival following supra-pharmacologic dosing of excipient-grade poloxamer 188 (P188-NF) and purified poloxamer 188 (P188-P) in remnant-kidney animals (n = 25 animals/group in each 24-h group; n = 30 animals/group in each 48-h group). Survival (%) = (number of animals alive at indicated time point/number of animals at t = 0)*100